Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users
about
Syringe access for the prevention of blood borne infections among injection drug usersEffectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugsPsychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug usersDo needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidenceState laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectivenessAre needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisSpatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel studyWhat is a vector?Harm reduction and 12 steps: complementary, oppositional, or something in-between?HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal studyA hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users.Dynamics of the HIV epidemic in southern China: sexual and drug-using behaviours among female sex workers and male clients in YunnanDecision making for HIV prevention and treatment scale up: bridging the gap between theory and practice.Impact of supervised injection facilities on community HIV levels: a public health perspective.Culture and interpersonal violence research: paradigm shift to create a full continuum of domestic violence services.High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviewsSyringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT studyConsequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk.Expanding the public health benefits of syringe exchange programs.Ethical perspectives in caring for people living with addictions: The European experience.Injecting drug use in low and middle-income countries: Opportunities to improve care and prevent harm.What about Us? Economic and Policy Changes Affecting Rural HIV/AIDS Services and Care.Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.Beyond needle sharing: meta-analyses of social context risk behaviors of injection drug users attending needle exchange programs.Injection risk behavior among women syringe exchangers in San Francisco.Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.HIV prevention for injection drug users in China and Vietnam: policy and research considerations.Evidence-Based Practice and Social Work.
P2860
Q21257250-D82FD7CF-0547-495A-8AC8-5E9AC8618EAEQ24186785-8B6E3A70-9DE4-4DDA-B944-CB0F531641AEQ24240762-D90AEB31-B719-4069-86F2-5B93A0B4863CQ28249288-1FAD9624-1323-4B3C-8932-044F376A84ADQ28255620-12D9D29E-7E41-4393-881A-F3DA58B0CC0AQ28304793-2A4E4232-BBC4-4F75-BF2B-DFBD0FC66E5FQ28710127-33F0F130-AA9B-47EF-B481-BAF3E4E57695Q30252972-E59C774F-2D00-47C8-AEB0-1D5F831C0943Q30400608-0C267992-0AA3-4E92-8343-E853C3A9D010Q33777428-01E06813-EABD-459A-9361-20CFE87CC875Q33833339-A2DEE65F-FC07-41E5-BBF6-3F50EC5763F9Q33906157-FD096E72-F0CC-42D4-BF2D-4B63E3F944A1Q35233571-4F7A4635-6863-403C-BC29-C28D14F2C8E9Q35324526-9855C404-A69A-4141-96F0-858C3F1E5AC2Q35729350-86F92447-6FE9-4BE2-BEB4-7A109E49E5CAQ35917274-CCA9955E-663E-4839-8B17-413E96BB39F8Q36049896-43CA2953-580E-41E2-BB75-3F59955917CAQ36123087-3B10F748-2930-4516-B3B2-149DA36AA527Q36343824-7A240B46-1086-43D5-84D1-4945B300FC4BQ36502510-C68A393D-1E72-45BE-9C72-090CCC4C981BQ36543096-DA7C8BA1-E880-4815-99D0-F6CC7B167284Q36902437-A0B48C45-BB9E-4A4B-B86D-BD82ECBDC837Q36939938-D7682CB0-E6BD-4BF4-B4A6-EE8EB508A079Q37272781-B11DDB93-C154-468C-BDE6-601CCBB725EEQ37763209-E9B18994-3989-46A6-9145-70AEE3F867A7Q38717150-4E78F173-07B7-446B-8216-DB5850A57EEFQ38918569-7440E0ED-9C09-4D70-BD10-7C38F0101125Q39559479-3C158C34-BA7F-4763-9240-2528841BAAEAQ39707513-038E7E3E-8F12-4047-9C1C-B6332FA35D01Q40048259-9C91B7D6-6376-49B5-8AF3-D425C1A546CAQ41585922-79862274-168A-4934-9356-7C64574B9658Q42599188-E2B95930-50CD-42A3-933C-61A7080E3B8AQ42671943-12EB8B80-89C0-4D90-9C7C-71CC083D9014Q42679741-F1C95EF2-37CA-49D0-9704-8550FC207020Q42720607-5871805F-9733-4A82-B207-5D33472F1FAFQ44302104-F27343A4-C951-498C-840F-7349CE9D4DB1Q45406601-63CED58B-03AD-47E9-A4EA-75DD056AF652Q45703854-85490ADF-5B14-4A80-BA57-41962E02AF75Q46091346-5AC9D34E-464C-4C1C-BD67-9DD37E7895E2Q50209191-3F20D92F-B589-4A34-9C7F-3ED85447B63D
P2860
Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users
description
article
@en
im Juli 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2001
@uk
ലേഖനം
@ml
name
Effectiveness of syringe excha ...... ion among injecting drug users
@en
Effectiveness of syringe excha ...... ion among injecting drug users
@nl
type
label
Effectiveness of syringe excha ...... ion among injecting drug users
@en
Effectiveness of syringe excha ...... ion among injecting drug users
@nl
prefLabel
Effectiveness of syringe excha ...... ion among injecting drug users
@en
Effectiveness of syringe excha ...... ion among injecting drug users
@nl
P2093
P1433
P1476
Effectiveness of syringe excha ...... ion among injecting drug users
@en
P2093
P304
P356
10.1097/00002030-200107270-00002
P407
P577
2001-07-01T00:00:00Z